Vita Life Sciences (ASX:VLS) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

VLS Stoklara Genel Bakış

Bir sağlık şirketi olan Vita Life Sciences Limited, Avustralya, Singapur, Malezya, Tayland, Vietnam, Endonezya ve Çin'de vitamin ve takviye edici gıdaların formüle edilmesi, paketlenmesi, dağıtımı ve satışı ile ilgilenmektedir.

Şirket hakkında

VLS temel anali̇z
Kar Tanesi Skoru
Değerleme	4/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	4/6
Finansal Sağlık	6/6
Temettüler	4/6

Ödüller

Adil değer tahminimizden 81.2% daha düşük bir oranda işlem görüyor

Kazançlar son 5 yılda yılda 19.8% oranında arttı

Risk Analizi

Kararsız temettü geçmişi

Anlamlı bir piyasa değeri yok ( A$126M )

Vita Life Sciences Limited Rakipler

Vitura Health

ASX:VIT

AU$42.0m

ECS Botanics Holdings

ASX:ECS

AU$23.8m

Neuren Pharmaceuticals

ASX:NEU

AU$1.9b

EZZ Life Science Holdings

ASX:EZZ

AU$200.7m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Vita Life Sciences
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	AU$2.22
52 Haftanın En Yüksek Seviyesi	AU$2.50
52 Haftanın En Düşük Seviyesi	AU$1.60
Beta	0.46
11 Aylık Değişim	-2.20%
3 Aylık Değişim	0.91%
1 Yıllık Değişim	30.59%
33 Yıllık Değişim	43.23%
5 Yıllık Değişim	263.93%
Halka arzdan bu yana değişim	1,205.88%

Son Haberler & Güncellemeler

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 23

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Aug 28

Recent updates

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 23

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

Aug 28

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14

Hissedar Getirileri

	VLS	AU Pharmaceuticals	AU Pazar
7D	2.8%	3.8%	1.1%
1Y	30.6%	98.5%	17.9%

Getiri vs. Endüstri: VLS geçen yıl % 98.5 oranında getiri sağlayan Australian Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: VLS geçen yıl % 17.9 oranında getiri sağlayan Australian Piyasasını aştı.

Fiyat Oynaklığı

Is VLS's price volatile compared to industry and market?
VLS volatility
VLS Average Weekly Movement	5.4%
Pharmaceuticals Industry Average Movement	10.4%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.6%
10% least volatile stocks in AU Market	3.6%

İstikrarlı Hisse Senedi Fiyatı: VLS son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: VLS 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1947	n/a	Andrew O'Keefe	vitalifesciences.com

Bir sağlık şirketi olan Vita Life Sciences Limited, Avustralya, Singapur, Malezya, Tayland, Vietnam, Endonezya ve Çin'de vitamin ve takviyeleri formüle etmekte, paketlemekte, dağıtmakta ve satmaktadır. Şirket ayrıca çeşitli mineraller, şifalı bitkiler ve süper gıdalar da sunmaktadır. Ayrıca, sinir sistemi; beslenme; üriner sağlık; kilo yönetimi; bağışıklık; cilt, saç ve tırnaklar; karaciğer ve sindirim; doğurganlık, hamilelik ve doğum sonrası; kan şekeri yönetimi; kardiyovasküler sağlık; ağrı ve iltihaplanma; erkek, kadın ve çocuk sağlığı; antioksidanlar; kemikler, eklemler ve kaslar; ve göz sağlığı gibi terapötik alanlar için ürünler sunmaktadır.

Vita Life Sciences Limited Temel Bilgiler Özeti

Vita Life Sciences'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
VLS temel i̇stati̇sti̇kler
Piyasa değeri	AU$126.05m
Kazançlar(TTM)	AU$9.39m
Gelir(TTM)	AU$79.17m

13.4x

F/K Oranı

1.6x

P/S Oranı

VLS aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
VLS gelir tablosu (TTM)
Gelir	AU$79.17m
Gelir Maliyeti	AU$32.77m
Brüt Kâr	AU$46.41m
Diğer Giderler	AU$37.01m
Kazançlar	AU$9.39m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.17
Brüt Marj	58.61%
Net Kâr Marjı	11.86%
Borç/Özkaynak Oranı	0%

VLS uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

4.1%

Mevcut Temettü Verimi

55%

Ödeme Oranı

VLS Stoklara Genel Bakış

Ödüller

Risk Analizi

Vita Life Sciences Limited Rakipler

ASX:VIT

AU$42.0m

ASX:ECS

AU$23.8m

ASX:NEU

AU$1.9b

ASX:EZZ

AU$200.7m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Upcoming dividend of AU$0.035 per share

First half 2024 earnings released: EPS: AU$0.078 (vs AU$0.074 in 1H 2023)

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

First half dividend increased to AU$0.035

Now 22% undervalued

Recent updates

Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough

Upcoming dividend of AU$0.035 per share

First half 2024 earnings released: EPS: AU$0.078 (vs AU$0.074 in 1H 2023)

Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035

First half dividend increased to AU$0.035

Now 22% undervalued

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Upcoming dividend of AU$0.06 per share

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences Limited, Annual General Meeting, May 15, 2024

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Final dividend increased to AU$0.06

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

New minor risk - Insider selling

Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023

Upcoming dividend of AU$0.03 per share at 3.7% yield

First half 2023 earnings released: EPS: AU$0.074 (vs AU$0.069 in 1H 2022)

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director

Investor sentiment improves as stock rises 15%

Upcoming dividend of AU$0.033 per share at 3.9% yield

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

No independent directors

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022

No independent directors

Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022

Non-Executive Chairman exercised options to buy AU$433k worth of stock.

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2021, Payable on April 7, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of AU$0.028 per share

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Independent Non-Executive Director Jonathan Tooth has left the company

Investor sentiment improved over the past week

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2021

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Investor sentiment improved over the past week

Upcoming Dividend of AU$0.028 Per Share

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

New 90-day high: AU$1.00

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?